Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine vs Desmopressin in Mono-symptomatic Nocturnal Enuresis
NCT06185361Active, not recruiting
- Sponsor
- Fayoum University Hospital
- Start
- Dec 2022
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Randomised trial of fluoxetine in nocturnal enuresis (NE), sponsored by Fayoum University Hospital. Primary endpoint: Response to therapy (non-responders, partial responders, or full responders) at 12 weeks. Started Dec 2022; status: active, not recruiting.
02
Drugs
fluoxetine
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT06185361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06185361.